| 8/24/2016 | CVLM | Exelixis calls $48.1 million 4.25% subordinated convertibles due 2019
|
| 8/22/2016 | CV | Market Commentary: Biotech names eyed after Medivation takeout news; BioMarin convertibles add with shares
|
| 8/22/2016 | CVLM | Exelixis to swap stock, cash for $71.3 million of 4.25% convertibles
|
| 8/9/2016 | CVLM | Exelixis to swap stock, cash for $168.1 million of 4.25% convertibles
|
| 7/1/2016 | CV | Market Commentary: Convertibles quiet ahead of holiday; Exelixis in line; Softbank/Alibaba mandatories better
|
| 7/1/2016 | CV | Market Commentary: Morning Commentary: Convertibles quiet ahead of holiday weekend; Exelixis trading in line
|
| 5/31/2016 | CV | Market Commentary: Health care in focus as sector lifts; Softbank mandatory exchangeable into Alibaba on tap
|
| 5/23/2016 | CV | Market Commentary: Convertibles mostly quiet; XenoPort surges on takeout news; Allegheny Technologies rises
|
| 3/2/2016 | CV | Market Commentary: Morning Commentary: Convertible bond market quiet at open; SunEdison’s 5% convertible stands at 56
|
| 3/1/2016 | CV | Market Commentary: Convertibles better as March gets underway; Seacor up; Exelixis expands; SunEdison swamped
|
| 3/1/2016 | CV | Market Commentary: Morning Commentary: Exelixis expands on swap on marketing pact; Workday in line as shares pop
|
| 1/5/2016 | CV | Market Commentary: Convertibles action picks up; tone improves; Exelixis bonds expand initially, then fade
|
| 1/5/2016 | CV | Market Commentary: Morning Commentary: Convertibles action picks up somewhat as broader markets steady; Exelixis eyed
|
| 8/11/2015 | CV | Market Commentary: Convertibles weaken; SunEdison, Tesla Motors down; PTC Therapeutics pulls off solid debut
|
| 8/11/2015 | CV | Market Commentary: Morning Commentary: New PTC Therapeutics holds up against weaker shares; Exelixis shares slip
|
| 7/21/2015 | CV | Market Commentary: Energy convertibles weak; Helix Energy down 2.5 points; United Tech mandatories in line
|
| 7/21/2015 | CV | Market Commentary: Morning Commentary: Whiting Petroleum weakens; Energy XXI down; United Tech mandatories in line
|
| 7/20/2015 | CV | Market Commentary: Exelixis jumps outright, expands on hedge on positive trial data; Depomed better on hedge
|
| 7/20/2015 | CV | Market Commentary: Morning Commentary: Exelixis jumps outright, expands on hedge on positive data; U.S. Steel drops
|
| 2/13/2015 | CV | Market Commentary: Newmont, Tesla remain weaker; Microchip adds on hedge; Exelixis up; Oclaro taps market
|
| 9/8/2014 | CV | Market Commentary: Convertibles muted as week kicks off; HSBC’s CoCo deal ahead; Exelixis looks for floor
|
| 9/3/2014 | CV | Market Commentary: Planned Depomed, Electronics For Imaging add in the gray; Huron Consulting notes on tap
|
| 9/3/2014 | CV | Market Commentary: Morning Commentary: New deals in focus; Clovis Oncology shares sharply lower; Exelixis slips
|
| 7/15/2014 | CV | Market Commentary: Morning Commentary: Citrix trading actively again; Macquarie adds; Blackstone trades at 108.5
|
| 7/14/2014 | CV | Market Commentary: Macquarie stretches to 107; Tesla flat to better on higher shares; Exelixis stock surges
|
| 3/26/2014 | CV | Market Commentary: New HomeAway trades up; Solazyme shares drop; Exelixis slumps outright, expands on hedge
|
| 1/27/2014 | CV | Market Commentary: Midday Commentary: Regis, Rayonier convertibles in focus as those shares make big swings
|
| 1/27/2014 | CV | Market Commentary: Regis trades lower outright, adds on hedge; Steel Dynamics in line on hedge; Ford in focus
|
| 1/7/2014 | CV | Market Commentary: Midday Commentary: Activity broadens out; volume still light; MGM, Exelixis gap higher
|
| 1/7/2014 | CV | Market Commentary: Tower Group jumps in active trade; MGM, Exelixis up outright, little changed on hedge
|
| 9/26/2013 | CV | Market Commentary: New Maiden mandatory holds at par against lower common stock; DryShips flat; Cemex in line
|
| 9/25/2013 | CV | Market Commentary: Maiden mandatory prices at the mids; deal eyed as cheap ahead of terms; Rallye prices
|
| 8/14/2012 | CV | Exelixis greenshoe exercised, lifts convertible sale to $287.5 million
|
| 8/10/2012 | CV | Market Commentary: MGM better on outright demand; Janus adds on investment stake; Hornbeck trades up, in line
|
| 8/9/2012 | CV | Market Commentary: New Exelixis gains on debut; new Prospect Capital prices at a discount; Medicis better
|
| 8/9/2012 | CV | New Issue: Exelixis sells upsized $250 million seven-year convertibles to yield 4.25%, up 25%
|
| 8/8/2012 | CV | Market Commentary: Isis pops on debut; older paper slips again; new Hornbeck adds; Tyson comes 'in' slightly
|
| 8/6/2012 | CV | Exelixis plans to price $225 million seven-year convertibles to yield 3.75%-4.25%, up 25%-30%
|
| 8/6/2012 | CV | Market Commentary: Knight extends strong gains on capital infusion; Isis moves up with shares, launches deal
|
| 6/8/2012 | CVHYPF | Exelixis files automatic shelf covering debt, stock and preferreds
|
| 4/24/2009 | CVHY | Exelixis files $250 million stock, debt securities shelf registration
|
| 10/27/2004 | CVHY | Exelixis files $200 million shelf
|
